Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2 ‐mediated PI3K / AKT pathway
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Jiankun Ren und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nursing School, Hebi Polytechnic, Hebi, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Diterpenes, Phenanthrenes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Triptolide (TP) has been found to have anti‐tumor effects. However, more potential molecular mechanisms of TP in the progression of non‐small cell lung cancer (NSCLC) deserve further investigation. Cell proliferation, apoptosis, invasion, and stemness were detected by cell counting kit 8 assay, EdU assay, flow cytometry, transwell assay, and sphere formation assay. Cell glycolysis was evaluated by corresponding assay kits. 6‐phosphofructo‐2‐kinase/fructose‐2,6‐biphosphatase 2 (PFKFB2) expression was measured by western blot (WB), qRT‐PCR and immunohistochemical staining. PI3K/AKT pathway‐related markers were determined by WB. Besides, xenograft tumor model was conducted to evaluate the anti‐tumor effect of TP in NSCLC. Our results revealed that TP treatment suppressed NSCLC cell proliferation, invasion, stemness, glycolysis, and enhanced apoptosis. PFKFB2 was upregulated in NSCLC tissues and cells, and its expression was decreased by TP. PFKFB2 knockdown restrained NSCLC cell functions, and its overexpression also eliminated TP‐mediated NSCLC cell functions inhibition. TP decreased PFKFB2 expression to inactivate PI3K/AKT pathway. Moreover, PI3K/AKT pathway inhibitor LY294002 also could reverse the promoting effect of PFKFB2 on NSCLC cell functions. In addition, TP suppressed NSCLC tumorigenesis by inhibiting PFKFB2/PI3K/AKT pathway. In conclusion, TP exerted anti‐tumor role in NSCLC, which was achieved by reducing PFKFB2 expression to inactivate PI3K/AKT pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nursing School, Hebi Polytechnic, Hebi, Henan, China.
- Department of Cardiology, Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Zitieren
APA
Ren, J., Zhao, S., & Lai, J. (2024). Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2 ‐mediated PI3K / AKT pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14450
Vancouver
Ren J, Zhao S, Lai J. Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2 ‐mediated PI3K / AKT pathway. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14450
BibTeX
@article{Ren2024,
author = {Ren, Jiankun and Zhao, Songwei and Lai, Junyu},
title = {Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2 ‐mediated PI3K / AKT pathway},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14450}
}
EUVIMED